Roveto; Philip M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roveto; Philip M..The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile

1.4.7

Roveto; Philip M. - Albuquerque NM
Roveto; Philip M. - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer Grant 11,407,721 - Bartberger , et al. August 9, 2	2022-08-09
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ; et al.	2022-06-02
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ; et al.	2021-06-17
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ; et al.	2019-02-28
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20180354918 - BARTBERGER; Michael D. ; et al.	2018-12-13
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2	2017-03-14
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer Grant 9,376,425 - Bartberger , et al. June 28, 2	2016-06-28
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2	2016-03-29
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160002185 - BARTBERGER; Michael D. ; et al.	2016-01-07
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ; et al.	2014-10-23
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20140235629 - Bartberger; Michael D. ; et al.	2014-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.